Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Neurocrine Biosciences: Q1 Earnings Insights

 

Neurocrine Biosciences (NASDAQ:NBIX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Neurocrine Biosciences missed estimated earnings by 11.76%, reporting an EPS of $0.3 versus an estimate of $0.34.

Revenue was up $74.00 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.48 which was followed by a 7.45% increase in the share price the next day.

Here's a look at Neurocrine Biosciences's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate 0.52 0.60 0.49 0.51
EPS Actual 0.04 0.64 0.63 0.49
Revenue Estimate 316.79M 297.65M 274.38M 250.63M
Revenue Actual 312.00M 296.00M 288.90M 236.60M

To track all earnings releases for Neurocrine Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.